Angela M Cacace sold $19k of ARVN
Chief Scientific Officer at ARVINAS, INC.. 2,583 shares at an average of $7.49, traded Jun 17, 2025, filed Jun 18, 2025.
Score components
- +15RoleOfficer
- 0Trade size$19k at market
- 0Share of holdings soldSold 1.6% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -1.6%, 3m +1.9%, 6m +56.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001655759-25-000105, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 17, 2025 | SOpen-market sale Common Stock | -2,583 | $7.49 | $19k | 154,248 | Jun 18, 2025 |
Related signals
Other insiders at ARVINAS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 16Weak | ARVINAS, INC. | Andrew Saik Chief Financial Officer | $46k 5,696 shares | -3% | |
| 3Weak | ARVINAS, INC. | Angela M Cacace Chief Scientific Officer | $20k 2,576 shares | -1% | |
| 40Moderate | ARVINAS, INC. | Randy Teel President and CEO | $20k 2,209 shares | -1% | |
| 50Moderate | ARVINAS, INC. | Randy Teel President and CEO | $96k 9,657 shares | -3% | |
| 40Moderate | ARVINAS, INC. | Noah Berkowitz Chief Medical Officer | $110k 11,108 shares | -5% | |
| 40Moderate | ARVINAS, INC. | Angela M Cacace Chief Scientific Officer | $96k 9,657 shares | -5% | |
| 30Weak | ARVINAS, INC. | David K Loomis VP, Chief Accounting Officer | $19k 1,919 shares | -5% | |
| 47Moderate | ARVINAS, INC. | Andrew Saik Chief Financial Officer | $111k 11,139 shares | -5% | |
| 23Weak | ARVNsell ARVINAS, INC. | Noah Berkowitz Chief Medical Officer | $71k 6,435 shares | -3% | |
| 38Weak | ARVNbuy ARVINAS, INC. | Briggs Morrison director | $268k 20,000 shares | +26% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.